Explore Treatments for Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a chronic condition that affects the central nervous system, which includes the brain, spinal cord, and optic nerves. In MS, the body’s immune system mistakenly attacks the protective covering of nerves called the myelin sheath. This damage disrupts how messages travel through the nervous system, leading to a wide range of symptoms including muscle weakness, difficulty with balance or coordination, numbness or tingling, blurred or double vision and blindness in one eye. There are different types of MS. The most common is relapsing MS, where symptoms come and go. People may experience “flare-ups” or relapses, followed by periods of recovery. In progressive MS, symptoms gradually worsen over time without clear relapses. While there is currently no cure for MS, there are treatments that can manage symptoms, treat flare-ups, and slow the progression of the disease. These treatments may include steroid medications (oral or injectable), plasma exchange therapy and newer disease-modifying medications. With the right care and support, many people with MS are able to manage their symptoms and maintain a good quality of life.

Treatments Offered by CSI

Immunoglobulins are derived from pooled human plasma collected from thousands of carefully screened donors. The plasma is rigorously processed and purified to ensure product safety and integrity. Intravenous immunoglobulin (IVIG) contains antibodies that provide broad protection against a wide range of bacteria and viruses. It is administered intravenously and is primarily used to treat three categories of conditions: primary immunodeficiency diseases, autoimmune disorders, and certain neurological conditions. 

  • Alyglo 10% 
  • Asceniv 10% 
  • Bivigam 10% 
  • Gammagard S/D 
  • Gammagard Liquid 10% 
  • Gammaked 10% 
  • Gamunex-C 10% 
  • Gammaplex 5% 
  • Gammaplex 10% 
  • Octagam 5% 
  • Octagam 10% 
  • Panzyga 10% 
  • Privigen 10% 
  • Yimmugo 10% 

Immunoglobulins are derived from pooled human plasma collected from thousands of carefully screened donors. The plasma undergoes rigorous processing and purification to ensure the highest standards of safety and product integrity. Subcutaneous immunoglobulin (SCIG) contains antibodies that offer broad protection against a wide range of bacteria and viruses. It is administered under the skin (subcutaneously) and is primarily used to treat primary immunodeficiency diseases and chronic inflammatory demyelinating polyneuropathy (CIDP). SCIG is also being studied in clinical trials for use in additional conditions. 

  • Cutaquig 16.5%  
  • Cuvitru 20% 
  • Gammagard Liquid 10% 
  • Gammaked 10% 
  • Gamunex-C 10% 
  • Hizentra 20% 
  • HyQvia 10% (facilitated SCIG)  
  • Xembify 20%